EntryPoint Capital’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-26,438
Closed -$339K 842
2025
Q3
$339K Sell
26,438
-32,122
-55% -$428K 0.13% 315
2025
Q2
$889K Buy
58,560
+27,101
+86% +$423K 0.45% 12
2025
Q1
$525K Buy
31,459
+7,422
+31% +$137K 0.24% 86
2024
Q4
$453K Buy
+24,037
New +$464K 0.19% 145
2024
Q3
Sell
-5,603
Closed -$106K 1246
2024
Q2
$106K Buy
5,603
+1,000
+22% +$17.1K 0.05% 787
2024
Q1
$74.8K Sell
4,603
-4,523
-50% -$66.2K 0.07% 566
2023
Q4
$116K Buy
+9,126
New +$115K 0.11% 310

Other funds holding SEM

EntryPoint Capital's SEM Position: Q4 2025 in Review

EntryPoint Capital sold out of Select Medical (SEM) in Q4 2025, closing a stake of 26,438 shares — an estimated $339K sold.

EntryPoint Capital first reported a position in SEM in Q4 2023 and held it in 7 quarters. The position peaked at $889K in Q2 2025. 268 funds tracked by Wall St. Rank hold SEM as of Q4 2025.

  • EntryPoint Capital reported no remaining Select Medical position as of Q4 2025 after selling out during the quarter.
  • EntryPoint Capital sold 26,438 Select Medical shares in Q4 2025, an estimated $339K.
  • EntryPoint Capital first reported a position in Select Medical in Q4 2023 and held it in 7 quarters.
  • EntryPoint Capital's Select Medical position peaked at $889K in Q2 2025.
  • 268 funds tracked by Wall St. Rank held Select Medical as of Q4 2025.

Based on EntryPoint Capital's 13F filing for Q4 2025, filed 12 Feb 2026.